Table 2.
Participant Characteristics Stratified According to the Presence or Absence of Disease Activity
| Characteristic | Inactive N = 141 | Active N = 101 | P |
|---|---|---|---|
| Age (years), mean (SD) | 46.4 (15.4) | 49.0 (14.0) | 0.17 |
| Women, n (%) | 87 (61.7) | 66 (65.4) | 0.56 |
| White, n (%) | 122 (87.1) | 84 (83.2) | 0.39 |
| >High school education, n (%) | 100 (70.9) | 70 (69.3) | 0.79 |
| Annual Income, n (%) | 0.006 | ||
| <$50,000 | 22 (15.6) | 33 (32.7) | |
| ≥$50,000 | 106 (75.2) | 63 (62.4) | |
| Declined | 13 (9.2) | 5 (4.9) | |
| IBD Subtype, n (%) | |||
| Crohn’s disease | 74 (52.5) | 75 (74.3) | <0.001 |
| Ulcerative colitis | 67 (47.5) | 26 (25.7) | |
| Immune therapy, n (%) | |||
| Any | 106 (75.2) | 76 (75.3) | 0.99 |
| Biologic | 36 (25.5) | 41 (40.6) | 0.013 |
| Oral corticosteroid | 3 (2.1) | 6 (5.9) | 0.17 |
| Irritable bowel syndrome, n (%) | 27 (19.2) | 34 (33.7) | 0.01 |
| HADS-D ≥ 11 | 4 (2.8) | 12 (11.9) | 0.005 |
| HADS-A ≥ 11 | 16 (11.4) | 24 (24.0) | 0.009 |
| HADS-D, mean (SD) | 2.9 (3.1) | 5.3 (3.9) | <0.001 |
| HADS-A, mean (SD) | 5.6 (3.9) | 7.4 (4.2) | <0.001 |
| Current smoker, n (%) | 18 (12.8) | 24 (23.8) | 0.026 |
| Physical comorbidity, n (%) | 0.017 | ||
| 0 | 55 (39.0) | 23 (22.8) | |
| 1 | 33 (23.4) | 24 (23.8) | |
| ≥2 | 53 (37.6) | 54 (53.5) |